|
CMTM1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.67859981259744E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.96750002348745E-09 |
| Normal-vs-Stage2 |
7.762300E-03 |
| Normal-vs-Stage3 |
3.29880000005112E-06 |
| Normal-vs-Stage4 |
1.27149999995524E-06 |
| Stage1-vs-Stage2 |
5.363200E-01 |
| Stage1-vs-Stage3 |
8.191600E-01 |
| Stage1-vs-Stage4 |
7.335600E-01 |
| Stage2-vs-Stage3 |
4.962000E-01 |
| Stage2-vs-Stage4 |
6.440200E-01 |
| Stage3-vs-Stage4 |
6.645000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.67119995619913E-09 |
| Normal-vs-AfricanAmerican |
1.982530E-04 |
| Normal-vs-Asian |
3.100200E-02 |
| Caucasian-vs-AfricanAmerican |
7.341200E-01 |
| Caucasian-vs-Asian |
1.166600E-01 |
| AfricanAmerican-vs-Asian |
1.079210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.06860001245235E-09 |
| Normal-vs-Female |
1.21909999872827E-08 |
| Male-vs-Female |
7.851200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.178900E-03 |
| Normal-vs-Age(41-60Yrs) |
3.94060006847496E-10 |
| Normal-vs-Age(61-80Yrs) |
5.77700000059522E-08 |
| Normal-vs-Age(81-100Yrs) |
2.561400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.456400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.391000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.490800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.460200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.422500E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.178000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.56079999947512E-07 |
| Normal-vs-Grade 2 |
4.09360001452086E-09 |
| Normal-vs-Grade 3 |
9.35229999998732E-07 |
| Normal-vs-Grade 4 |
1.177090E-04 |
| Grade 1-vs-Grade 2 |
1.209640E-01 |
| Grade 1-vs-Grade 3 |
3.049900E-02 |
| Grade 1-vs-Grade 4 |
6.570300E-02 |
| Grade 2-vs-Grade 3 |
9.672000E-02 |
| Grade 2-vs-Grade 4 |
5.418400E-01 |
| Grade 3-vs-Grade 4 |
6.181000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.33099999805242E-08 |
| Normal-vs-ccB subtype |
1.11350000331356E-08 |
| ccA subtype-vs-ccB subtype |
2.539600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.30149948782832E-10 |
| Normal-vs-N1 |
1.330420E-02 |
| N0-vs-N1 |
6.560000E-01 |
|
|
